These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17882490)

  • 1. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
    Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
    Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
    Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
    Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.
    Guillem JG; Ruby JA; Leibold T; Akhurst TJ; Yeung HW; Gollub MJ; Ginsberg MS; Shia J; Suriawinata AA; Riedel ER; Mazumdar M; Saltz LB; Minsky BD; Nash GM; Paty PB; Temple LK; Weiser MR; Larson SM
    Ann Surg; 2013 Aug; 258(2):289-95. PubMed ID: 23187748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study.
    Ding P; Liska D; Tang P; Shia J; Saltz L; Goodman K; Downey RJ; Nash GM; Temple LK; Paty PB; Guillem JG; Wong WD; Weiser MR
    Ann Surg; 2012 Jul; 256(1):111-6. PubMed ID: 22664562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
    Hunter CJ; Garant A; Vuong T; Artho G; Lisbona R; Tekkis P; Abulafi M; Brown G
    Ann Surg Oncol; 2012 Apr; 19(4):1199-205. PubMed ID: 21913017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M
    Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.
    Calvo FA; Domper M; Matute R; Martínez-Lázaro R; Arranz JA; Desco M; Alvarez E; Carreras JL
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):528-35. PubMed ID: 14751524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
    Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
    Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
    Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
    Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
    Omarov N; Uymaz DS; Kulle CB; Ozkan ZG; Azamat S; Keskin M; Bulut MT
    Pol Przegl Chir; 2022 Feb; 94(6):10-16. PubMed ID: 36468505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer.
    Ozis SE; Soydal C; Akyol C; Can N; Kucuk ON; Yagcı C; Erkek AB; Kuzu MA
    World J Surg Oncol; 2014 Feb; 12():26. PubMed ID: 24484935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
    Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
    Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
    Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
    Jaffe TA; Neville AM; Bashir MR; Uronis HE; Thacker JM
    Colorectal Dis; 2013 Nov; 15(11):e654-8. PubMed ID: 23910050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
    Moore HG; Akhurst T; Larson SM; Minsky BD; Mazumdar M; Guillem JG
    J Am Coll Surg; 2003 Jul; 197(1):22-8. PubMed ID: 12831920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
    Capirci C; Rubello D; Chierichetti F; Crepaldi G; Fanti S; Mandoliti G; Salviato S; Boni G; Rampin L; Polico C; Mariani G
    AJR Am J Roentgenol; 2006 Aug; 187(2):W202-8. PubMed ID: 16861513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.